Showing results (1661-1670 of 1,995) with videos related to

Sort By:
Pageof 200
Pathology|October 8, 2025
Clinicopathological features of primary epidural B-cell lymphoma: a study of 14 casesWei J Wang, Zhihong Hu, Brandon T Gehris, et al.
Oncoimmunology|September 22, 2017
The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanismsTatiana Pazina, Ashley M James, Alexander W MacFarlane, et al.
Archives of Pathology & Laboratory Medicine|May 1, 2013
Plasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by fluorescence in situ hybridization and improves risk stratification of patients with plasma cell neoplasmsGary Lu, Ramya Muddasani, Robert Z Orlowski, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 29, 2021
Tumor necrosis factor receptor superfamily member 25 (TNFRSF25) agonists in islet transplantation: Endogenous in vivo regulatory T cell expansion promotes prolonged allograft survivalBraulio A Marfil-Garza, Rena L Pawlick, Jake Szeto, et al.
Translational Psychiatry|June 14, 2017
The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learningA Kautzky, G M James, C Philippe, et al.
The Lancet. Diabetes & Endocrinology|May 19, 2022
Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in CanadaBraulio A Marfil-Garza, Sharleen Imes, Kevin Verhoeff, et al.
Plos Genetics|March 4, 2014
miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasionDahu Chen, Yutong Sun, Yuan Yuan, et al.
The International Journal of Biochemistry & Cell Biology|November 7, 2012
Characterization of fibrinogen-like protein 2 (FGL2): monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2Hao Liu, Peter S Yang, Tina Zhu, et al.
British Journal of Haematology|June 6, 2024
The impact of sickle cell disease and its treatment on ovarian reserve in reproductive-aged Black womenLisa M Shandley, Ross M Fasano, Jessica B Spencer, et al.
JCI Insight|February 3, 2026
A dual-reporter mouse for therapeutic discovery in Angelman syndromeHanna Vihma, Lucas M James, Hannah C Nourie, et al.
Pageof 200